SALIOLA, Mirella
 Distribuzione geografica
Continente #
EU - Europa 99
NA - Nord America 89
AF - Africa 2
Totale 190
Nazione #
IT - Italia 93
US - Stati Uniti d'America 88
FR - Francia 5
ZA - Sudafrica 2
CA - Canada 1
DE - Germania 1
Totale 190
Città #
Rome 68
Milan 23
Fairfield 11
Ashburn 10
Santa Cruz 10
Buffalo 8
Seattle 5
Woodbridge 5
Cambridge 4
Dallas 3
Houston 3
Chicago 2
Las Vegas 2
Muizenberg 2
Wilmington 2
Ann Arbor 1
Boardman 1
Lake Forest 1
Los Angeles 1
Mainz 1
Ottawa 1
Paris 1
Phoenix 1
San Cesareo 1
San Francisco 1
Totale 168
Nome #
Relationship between low Ankle-Brachial Index and rapid renal function decline in patients with atrial fibrillation: a prospective multicentre cohort study, file e383531e-a71f-15e8-e053-a505fe0a3de9 91
Relationship between low Ankle-Brachial Index and rapid renal function decline in patients with atrial fibrillation: a prospective multicentre cohort study, file e383531e-9061-15e8-e053-a505fe0a3de9 16
Cancer-specific ischemic complications in elderly Patients with atrial fibrillation. data from the prospective ATHERO-AF study, file e3835327-62e1-15e8-e053-a505fe0a3de9 11
Aspirin and renal insufficiency progression in patients with atrial fibrillation and chronic kidney disease, file e3835316-df2d-15e8-e053-a505fe0a3de9 9
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study, file e383531a-610a-15e8-e053-a505fe0a3de9 8
Inadequate anticoagulation by vitamin K antagonists is associated with major adverse cardiovascular events in patients with atrial fibrillation, file e383531e-8dab-15e8-e053-a505fe0a3de9 6
Reply to. "inadequate anticoagulation by vitamin K antagonists and major adverse cardiovascular events other than stroke", file e383531e-c4d0-15e8-e053-a505fe0a3de9 6
Coexistence of anti-phospholipid antibodies and endothelial perturbation in systemic lupus erythematosus patients with ongoing prothrombotic state, file e3835311-a347-15e8-e053-a505fe0a3de9 5
Relationship between Mediterranean diet and time in therapeutic range in atrial fibrillation patients taking Vitamin K antagonists, file e3835315-497d-15e8-e053-a505fe0a3de9 5
Incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants, file e3835321-cc3e-15e8-e053-a505fe0a3de9 5
Serum NOX2 and urinary isoprostanes predict vascular events in patients with atrial fibrillation, file e3835311-d145-15e8-e053-a505fe0a3de9 4
Interaction between serum endotoxemia and proprotein convertase subtilisin/kexin 9 (PCSK9) in patients with atrial fibrillation. a post-hoc analysis from the ATHERO-AF cohort, file e3835323-40b5-15e8-e053-a505fe0a3de9 4
Reply to. "monitoring antivitamin K anticoagulants in antiphospholipid syndrome. a challenge in quality", file e3835328-2a65-15e8-e053-a505fe0a3de9 4
The risk of myocardial infarction in patients with atrial fibrillation: an unresolved issue, file e3835311-6c82-15e8-e053-a505fe0a3de9 3
Vitamin E serum levels and bleeding risk in patients receiving oral anticoagulant therapy. A retrospective cohort study, file e3835312-32e3-15e8-e053-a505fe0a3de9 3
Relationship of PCSK9 and urinary thromboxane excretion to cardiovascular events in patients with atrial fibrillation, file e383531d-789e-15e8-e053-a505fe0a3de9 3
Determinants of low-quality warfarin anticoagulation in patients with mechanical prosthetic heart valves. the nationwide PLECTRUM study, file e3835325-4642-15e8-e053-a505fe0a3de9 3
Atrial fibrillation pattern, left atrial diameter and risk of cardiovascular events and mortality. a prospective multicenter cohort study, file e3835329-1b9c-15e8-e053-a505fe0a3de9 3
Long-term risk of major adverse cardiac events in atrial fibrillation patients on direct oral anticoagulants, file e383532a-bc9f-15e8-e053-a505fe0a3de9 3
Mediterranean Dietary Pattern Adherence: Associations with Prediabetes, Metabolic Syndrome, and Related Microinflammation, file e3835312-5830-15e8-e053-a505fe0a3de9 2
Temporal trends of time in therapeutic range and incidence of cardiovascular events in patients with non-valvular atrial fibrillation, file e3835321-ced3-15e8-e053-a505fe0a3de9 2
Antiphospholipid syndrome and anticoagulation quality: A clinical challenge, file e3835314-4cfc-15e8-e053-a505fe0a3de9 1
Prevalence and Impact of Nonalcoholic Fatty Liver Disease in Atrial Fibrillation, file e3835324-0f3d-15e8-e053-a505fe0a3de9 1
Time to therapeutic range (TtTR), anticoagulation control, and cardiovascular events in vitamin K antagonists–naive patients with atrial fibrillation, file e3835324-4d95-15e8-e053-a505fe0a3de9 1
Totale 199
Categoria #
all - tutte 351
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 351


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201912 0 0 0 0 0 0 0 0 0 3 1 8
2019/202031 1 1 6 1 2 3 4 3 3 3 1 3
2020/202176 4 2 2 9 0 1 1 1 11 33 9 3
2021/202220 1 1 1 0 2 0 1 1 0 2 9 2
2022/202326 0 2 13 2 3 3 1 2 0 0 0 0
2023/20248 0 1 1 0 1 3 0 1 1 0 0 0
Totale 199